Carfilzomib (PR-171)

Carfilzomib (PR-171)

Catalog Number:
I002097727UBP
Mfr. No.:
F1300
Price:
$280
  • Size:
    5 mg
    Quantity:
    Add to Cart:
    Add to Cart
      • Overview

        • Carfilzomib is a derivative of the microbially-derived natural product epoxomycin. It irreversibly inhibits the chymotrypsin-like activity of the 20S proteasome with high potency and selectivity at several orders of magnitude over epoxomycin. In 2012, Carfilzomib was approved by the FDA for use in patients with relapsed and refractory multiple myeloma. It is in clinical trials for other cancers as well.

          Please contact us at for specific academic pricing.

      • Properties
        • Protein Name
          PR-171; CAS# 868540-17-4
          Source
          Synthetic
          Formulation
          Powder
          Storage
          Eligible for room temperature shipping. Store at -20°C upon receiving; protect from air and light
          Concentration
          N/A
          Molecular Weight
          719.42Da

          * Research Use Only

    Datasheet
    MSDS

    We Also Recommend

    Carfilzomib (PR-171)

    Carfilzomib (PR-171)

    $280

    Carfilzomib (PR-171)

    Carfilzomib (PR-171)

    $552

    PS-341

    PS-341

    $720

    PS-341

    PS-341

    $306

    PS-341

    PS-341

    $170